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Abstract
Recently, fear–avoidance models have been quite influential in understanding the transition from acute to chronic low back pain (LBP).
Not only has pain-related fear been found to be associated with disability and increased pain severity, but also treatment focused at reducing
pain-related fear has shown to successfully reduce disability levels. In spite of these developments, there is still a lack in well-designed
prospective studies examining the role of pain-related fear in acute back pain. The aim of the current study was to prospectively test the
assumption that pain-related fear in acute stages successfully predicts future disability. Subjects were primary care acute LBP patients
consulting because of a new episode of LBP (%3 weeks). They completed questionnaires on background variables, fear–avoidance model
variables and LBP outcome (Graded Chronic Pain Scale, GCPS) at baseline, 3, 6, and 12 months follow-up and at the end of the study. Two-
hundred and twenty-two acute LBP patients were included, of whom 174 provided full follow-up information (78.4%). A backward ordinal
regression analysis showed previous LBP history and pain intensity to be the most important predictors of end of study GCPS. Of the fear–
avoidance model variables, only negative affect added to this model. Our results do not really support the longitudinal validity of the fear–
avoidance model, but they do feed the discussion on the role of pain-related fear in early stages of LBP.
q 2005 Published by Elsevier B.V. on behalf of International Association for the Study of Pain.
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1. Introduction
Back in 1996, Gordon Waddell (1996) called non-
specific low back pain (LBP) “a twentieth century health
care enigma”. Now, we have come to the twenty-first
century, and still the puzzle has not been solved. With
lifetime incidence rates as high as 70–85% (Andersson,
1999), LBP is one of the most important medical problems
in western societies. Although self-limiting in most cases,
many face recurrences and some even develop a chronic
condition, with severe consequences for both patients and
society.
As Pincus et al. (2002) pointed out in their review, the
importance of psychosocial factors in LBP is well accepted,
and evidence-based clinical guidelines on LBP are
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consistent in adopting a biopsychosocial perspective
(Bekkering et al., 2001; Faas et al., 1996; Kendall et al.,
1997). A specific theoretical concept developed over the last
decade in chronic LBP patients is the fear–avoidance model
(Vlaeyen and Linton, 2000). The basic tenet of the fear–
avoidance model is that when LBP is being misinterpreted
as a sign of serious injury, patients (especially those in
negative mood who tend to catastrophize about their pain)
might develop pain-related fear and subsequent avoidance
of movements that are believed to be harmful. Persisting
avoidance behaviour will cause increasing disability and
physical deconditioning as a result of inactivity. Fearful
patients are at risk of becoming trapped in a cycle of pain,
fear, disability, and depressive symptoms.
Several studies addressed the predictive value of acute
stage fear–avoidance variables in explaining LBP prog-
nosis. Research done by Fritz et al. (2001) showed fear–
avoidance beliefs to predict disability and work status 4
weeks later, even after controlling for initial levels of pain
and impairment. Klenerman et al. (1995) reported fear–
avoidance variables to be the strongest predictors for 12-
month course of LBP. In the general population, pain-
related fear and pain catastrophizing predicted LBP and
disability 6 months later (Picavet et al., 2002). Similar
results were found by Buer and Linton (2002), showing a
relationship between fear–avoidance and activities of daily
living in a sample of pain-free individuals and patients with
non-chronic spinal pain. Linton et al. (2000) suggested that
fear–avoidance beliefs are related to the inception of LBP.
Finally, previous research by our group (Sieben et al., 2002)
showed that rising fear during the first 2 weeks of a new
LBP episode was associated with higher disability at 1-year
follow-up. In contrast, only one study was traced in which
fear–avoidance beliefs were not retained in a multivariate
model including several psychological predictors in a mixed
sample of acute and subacute LBP patients (Burton et al.,
1995).
The methods used in these previous studies are very
diverse with respect to sample selection, follow-up time,
outcome measures, predictor variables, and analyses.
Although the results are important, generalisation is difficult
and more rigorous prospective studies are needed. Aim of
the present study is to test the longitudinal validity of the
fear–avoidance model; the research question to be answered
is whether acute stage pain-related fear predicts long-term
LBP outcome after adjustment for known risk factors.
2. Methods
2.1. Subjects
Patient recruitment was carried out from January 2001 to April
2003 by 35 Dutch general practices joined in the Coordination
Centre Primary Care (CEL) and/or the Registration Network of
Family Practices (RNH) (Metsemakers et al., 1992). Both CEL and
RNH are primary care research networks affiliated to the
Department of General Practice of Maastricht University.
The general practitioners (GPs) invited primary care patients
who consulted because of a new episode of non-specific LBP to
participate in this study. A new episode of LBP was defined as: (1)
pain localised below the scapulae and above the gluteal folds
(following IASP taxonomy; Merskey and Bogduk, 1994); (2) time
since pain onset no longer than 3 weeks; (3) after at least 3 months
without relevant activity limitations due to LBP.
Exclusion criteria were (1) age younger than 18 or older than 60
years, (2) (suspected) specific cause of LBP (such as lumbar disc
herniation with neurological complaints, tumour or vertebral
fracture), (3) other major disease or psychiatric disorder (as far
as known to the GP), (4) pregnancy, and (5) insufficient knowledge
of Dutch language to complete a questionnaire. Selection criteria
were initially checked by the GPs and later rechecked by the
researchers.
After the GP-consultation, eligible patients received full written
information about the study to read at home. Within the next days,
potential participants were contacted by phone. Any questions
about the study were answered, and when agreeing on participation
the patient was asked to return the baseline questionnaire together
with the signed informed consent form.
2.2. Ethics
The study protocol was approved by the medical ethics review
committees of Maastricht University Hospital and Maastricht
University (Maastricht, The Netherlands) and the Institute for
Rehabilitation Research (Hoensbroek, The Netherlands).
2.3. Baseline questionnaire
Within a few days after the GP visit participants completed the
baseline questionnaire. This questionnaire consisted of (a) a set of
descriptives such as work status, back pain history, and
characteristics of the current episode and (b) measures concerning
the fear–avoidance model.
2.3.1. Work status
To explore the occupational context, items covering employ-
ment status, occupation, sick leave, and job satisfaction were
included in the questionnaire.
2.3.2. Back pain history
The patient’s back pain history was characterised by the
number of episodes in the past, age at which the first episode
occurred and history of back pain treatment. Both work status and
back pain history items were designed for this study (but based on
previous questionnaires).
2.3.3. Current LBP episode
The current LBP episode was described by (a) type of pain
onset (sudden/gradual) and (b) presence of radiating symptoms
(yes/no). Both these items are derived from the McGill Pain
Questionnaire, Dutch Version (Verkes et al., 1989). An additional
item covered acute pain duration (number of days since LBP
onset).
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2.3.4. Pain intensity
Pain intensity was measured by a 10 cm Visual Analogue Scale
(VAS) with extremes of 0 (‘no pain’) and 100 (‘unbearable pain’)
(Jensen and Karoly, 1992).
2.3.5. Negative affect
Negative affect was assessed by the Dutch Version of the
Negative Emotionality Scale (NEM), which contains 14 dichot-
omous items derived from the Multidimensional Personality
Questionnaire (Stegen et al., 1998). The NEM does not contain
any items concerning somatic complaints. The Dutch version NEM
scale is known for good reliability and validity (Crombez et al.,
1999; Stegen et al., 1998).
2.3.6. Pain catastrophizing
A Dutch version of the Pain Catastrophizing Scale (PCS)
(Sullivan et al., 1995) was used in this study to determine patients’
thoughts and feelings about pain. This scale consists of 13 items.
Patients indicate on a 5-point scale the extent to which they have an
exaggerated negative view of their pain. The PCS has been shown
to have good reliability and validity (Osman et al., 1997; Van
Damme et al., 2002).
2.3.7. Pain-related fear
The level of pain-related fear was measured by the Tampa Scale
for Kinesiophobia (Dutch Version) (Miller et al., 1991; Vlaeyen et
al., 1995). This 17-item 4-point scale questionnaire was designed
for use in back pain populations. Two subscales represent
constructs of somatic focus (five items) and activity avoidance
(eight items). Reliability and validity of the TSK Dutch version and
its subscales are good (Roelofs et al., 2004; Vlaeyen et al., 1995).
2.3.8. Physical disability
To assess LBP related physical disability, the Quebec Back
Pain Disability Scale (QBPDS) (Kopec et al., 1996) was used,
which was developed specifically for LBP populations. To express
the level of difficulty experienced in performing activities in daily
life, patients rate a 6-point Likert scale (0Z‘no difficulty’ to 5Z
‘not able to do’) for 20 selected activities such as getting dressed,
climbing the stairs, and making the bed. The Dutch version is both
reliable and valid (Schoppink et al., 1996).
2.3.9. Social interference
As recommended by Deyo et al. (1998), interference of LBP
with social functioning is measured by a set of items covering
absence from work and/or other normal daily activities, sports,
leisure time activities, and time spent in bed because of LBP. These
items are derived from the National Health Interview Survey, have
been validated for use in LBP patients by Patrick et al. (1995), and
were successfully applied before in the Maine Lumbar Spine Study
(Atlas et al., 1996; Patrick et al., 1995). For use in the present study
the questions have been translated into Dutch.
2.3.10. (Avoidance of) physical activity
The Physical Activity Rating Scale (PARS) (Vercoulen et al.,
1997) was used to determine to what extent subjects engage in
daily life activities (e.g. shopping, 1 h walking). Patients were
asked to indicate on a 5-point scale (‘never’ to ‘very often’)
whether they had performed each of 20 activities over the previous
2 weeks. The PARS was initially developed for application in
chronic fatigue syndrome and was previously used in low back
pain research by Verbunt et al. (in press). For this study, a newly
designed question was added to the PARS scale to measure
physical avoidance behaviour. After having rated activity
frequencies, patients were asked for each item whether they
would have performed the activity more often if they would not
have taken their back pain into account. The sum of all 20
dichotomous answers (yesZ1, noZ0), with higher scores
indicating more avoidance behaviour, was used as a measure of
avoidance in our analysis.
2.3.11. Depression
The level of depression was assessed using the Beck Depression
Inventory (BDI) (Beck et al., 1961). The BDI consists of 21 items
and is a widely used self-report measure of depressive symptoms in
clinical and non-clinical populations. Answers are on a 4-point
scale, and two subscales reflect a negative view of self (six items)
and a somatic factor (seven items) (Morley et al., 2002). The
somatic factor was not evaluated in this study because of its
conceptual overlay with other measures (TSK, PCS); only the
‘negative view of self’ subscale was used in analysis. Validity and
reliability of the Dutch version of the BDI are well established
(Bosscher et al., 1986).
2.4. Follow-up
Follow-up questionnaires containing all measures related to the
fear–avoidance model (pain intensity, negative affect, pain
catastrophizing, pain-related fear, physical disability, social
interference, avoidance of activities, depression) were sent by
mail to the participants at 3, 6, and 12 months after the index GP
visit. Non-responders were first reminded by telephone, and if
necessary, received a written reminder together with another copy
of the questionnaire.
At the end of the project (April 2004), when 12-months’ follow-
up for all participants were complete, a brief questionnaire
assessing LBP outcome was sent to all participants at the same
time (thus achieving a maximum follow-up of 40 months for those
patients first enrolled in January 2001). A maximum of one
reminder was sent to enhance response to this final cross-sectional
measurement.
2.5. Outcome
As a primary outcome the Graded Chronic Pain Scale (GCPS)
(Von Korff et al., 1992) was used. This instrument was developed
from the point of view that primary care LBP should not be
regarded as either acute or chronic depending on the duration of the
complaints, but rather as recurrent episodes characterised by
variable severity. The GCPS consists of seven items measuring
aspects of pain, physical disability, and social interference
resulting in a 5-class hierarchical scale: 0Zno pain problem, IZ
low disability/low pain intensity, IIZlow disability/high pain
intensity, IIIZhigh disability/moderately limiting, IVZhigh
disability/severely limiting. The low range of this pain grading is
typically characterised by pain intensity levels, while the high
range of the scale is described by differences in disability levels.
Differences between grades were shown to be clinically relevant
(Von Korff et al., 1992). Higher GCPS grades were found to be
associated with higher levels of pain, disability and depression,
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poor self-reported quality of health, more doctor visits and higher
health care costs (Engel et al., 1996; Penny et al., 1999; Smith et
al., 1997; Von Korff et al., 1992). Its responsiveness to changes
over time was shown to be good (Elliott et al., 2000).
In the present study, the Graded Chronic Pain Scale was applied
at the cross-sectional end of study measurement. For all other
measurements, an adaptation of the GCPS classification was
derived from scores on pain, physical disability and social
interference measures (details available from corresponding
author). Calculation methods were refined by expert opinion and
validated by comparison with data from similar samples (Von
Korff, 2001; Von Korff et al., 1993).
2.6. Analysis
SPSS 11.5 (SPSS, Chicago, USA) was used for all statistical
analyses. Because most variables showed non-normal distri-
butions, non-parametric statistics were applied. Unless reported
otherwise, statistical tests are two-sided and P-values%0.05 are
judged significant.
Bivariate associations between fear–avoidance model variables
as assessed at baseline and LBP outcome (GCPS) at each of the
follow-up moments were examined by Spearman rank correlation
coefficients.
2.6.1. Primary analysis
Eight known or presumed ‘standard’ risk factors (age, gender,
number of days since pain onset, number of previous episodes,
radiating symptoms (yes/no), type of onset (sudden/gradual), level
of education, pain intensity) were evaluated for their contribution
in explaining outcome (GCPS at end of study). Because of distinct
non-normality of the outcome scores, an ordinal regression model
(available through SPSS procedure PLUM (polytomous logit
universal models)) was used. First, a backward regression analysis
was applied to determine a restricted subset of these variables for
use in subsequent analyses. Next, the additional predictive value of
baseline pain-related fear variables was tested. The standard risk
factors resulting from the previous analysis were forced into the
model and were kept. Then baseline TSK-somatic focus, TSK-
activity avoidance, disability (QBPDS), follow-up time and
interaction effects (fear–avoidance variables by follow-up time)
were added and possibly deleted as part of the backward strategy.
For each removal step likelihood-ratio tests were used to test the
significance of the change in K2 loglikelihood. Steps were
repeated until all remaining variables were significant contributors
to the model or until no variables were left to delete. For each
variable in the final model parameter estimates, odds ratios and
95% confidence intervals were calculated.
2.6.2. Secondary analysis
Similar analyses were performed using 3, 6, and 12 months’
chronic pain grades (GCPS) scores as a dependent variable
successively (without testing for interaction effects as follow-up
intervals were constant). Furthermore, the value of 3 and 6 months’
fear–avoidance variables in predicting end of study GCPS was
tested using the same strategy as in primary analysis. Finally,
analyses were repeated once more entering all baseline fear–
avoidance variables together as independent variables to determine
the predictive value of the entire fear–avoidance model.
3. Results
3.1. Subject characteristics
The GPs invited 464 of their patients to participate. Of
them, 81 refused to participate, 136 did not meet the
selection criteria (mostly because of pain duration O3
weeks) and 25 with TSK scores R42 were excluded
because they participated in the intervention group of a
trial study (RCT) that was conducted within the cohort.
Selection criteria were met and informed consent was
given by 222 general practice acute LBP patients. General
characteristics of this sample are presented in Table 1. The
majority of patients consulted their GP within 1 week from
LBP onset (medianZ5 days; interquartile range 2–10).
Table 1
Subject characteristics at baseline (NZ222)
Variable Category N %





Gender Male 125 56.3
Female 97 43.7















































%7 days 146 65.8
8–14 days 44 19.8
R15 days 32 14.4
a Disability retirement/sickleave not necessarily due to LBP.
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About three-quarters of the participants reported a history
of back pain. There were no significant differences (age,
gender) between participants and non-participants (data
were available from 89 non-participants).
3.2. Follow-up
Response rates during follow-up are shown in Table 2.
No differences were found between responders and non-
responders, except for age; non-responders tended to be
younger (significant at 12 months and end of study). The
end of study cross-sectional data collection resulted in a
median follow-up time of 1.9 years (minimumZ1.1;
maximumZ3.1 years). Follow-up data covered a total
amount of 327.7 patient years.
3.3. Outcome
Frequencies of Graded Chronic Pain Scale scores are
reported in Fig. 1. Although many participants reported to
be free of pain during follow-up, the largest group was
categorized at grade I (low disability–low pain). About 15%
of all patients showed poor outcome (grades III and IV).
Spearman’s correlation between GCPS-scores as measured
with the original instrument (end of study) and the adapted
GCPS-scores at 12 months was 0.701 for those who
completed both questionnaires within a 3 months’ time
span. This sufficient consistency suggests that the adaptation
of the GCPS instrument was performed successfully.
3.4. Associations between fear–avoidance variables and
LBP outcome
Table 3 shows descriptives of fear–avoidance model
variables at baseline and correlations with follow-up
chronic pain grades (GCPS). Significant but weak associ-
ations were found between end of study GCPS and all fear–
avoidance variables except TSK-somatic focus. For shorter
follow-up intervals only pain catastrophizing and avoidance
of activity appeared to be associated with chronic pain
grade. The BDI subscale ‘negative view of self’ was only
significantly related to outcome at 6 and 12 months. Both
TSK subscales were associated to baseline GCPS scores but
not to follow-up. Note that the correlations found for pain
intensity and disability with GCPS are inherent to the way
GCPS scores are calculated from pain and disability items.
3.5. Ordinal regression analysis results
Ofthestandardriskfactors,age, levelofeducation,number
of previous episodes and pain intensity contributed to the
prediction of outcome (results consistent for all follow-up
measurements) and were selected for use in further analyses.
A backward procedure was carried out to determine the
additional predictive value of pain-related fear in explaining
end of study chronic pain grade (Table 4).
According to the backward elimination approach, all
pain-related fear variables and interaction effects with
follow-up time were removed from the model. Details for
the final model are presented in Table 5. Odds ratios and
confidence intervals showed number of previous episodes
and baseline pain intensity to be significant risk factors.
Another backward procedure was carried out to
determine the predictive value of several fear–avoidance
model variables together. Pain catastrophizing (PCS) was
kept out of the model because of its conceptual overlay and
correlation with pain-related fear (TSK) and negative affect
(NEM). The remaining six fear–avoidance variables
(negative affect, TSK-somatic focus, TSK-activity avoid-
ance, avoidance of activities, BDI negative view of self and
disability) were subject to stepwise removal; age, pain
intensity, number of previous episodes and level of
education were initially entered and not to be removed.
Grade IV: severe disability
Grade III: high disability 
Grade II: low disability / high pain
Grade I: low disability / lowpain
Grade 0: noback pain problem
Graded Chronic Pain Scale
175




































165 169217 167Valid n




Selection criteria and informed consenta 222 100.0
Baselineb 220 99.1
3 monthsb 180 81.1
6 monthsb 168 75.7
12 monthsb 171 77.0
End of studyb 174 78.4
a Number of participants included.
b Number of questionnaires returned.
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Table 3














NEM 4 1–7 0.014 0.098 0.074 0.143 0.215*
Pain intensity
(VAS)
48 27–64 0.501* 0.303* 0.128 0.144 0.186*
PCS 13 8–20 0.226* 0.205* 0.254* 0.174* 0.189*
Avoidance of
activity
2 0–7 0.405* 0.180* 0.255* 0.249* 0.175*
BDI-neg. view
self
0 0–1 0.094 0.104 0.165* 0.197* 0.265*
TSK-somatic
focus
8 7–10 0.159* 0.092 K0.023 0.100 0.110
TSK-act. avoid-
ance
16 13–20 0.284* 0.145 K0.070 0.092 0.184*
QBPDS 41 28–54 0.728* 0.222* 0.130 0.236* 0.233*
P-values%0.05 are marked *.
a Spearman’s r correlation coefficients are presented.
b Descriptives are baseline values: Q1–Q3Zinterquartile range.
Table 4
Backward stepwise regression analysis report with end of study Graded Chronic Pain Scale as a dependent variable and baseline pain-related fear





K2LL df R2 LR test Sign.


















1 a, b, d–h [c] disability 49.999 10 0.286 0.005 0.944
2 a, b, d–f, h [g] follow-up
TSK somatic
focus
49.720 9 0.285 0.279 0.597
3 a, b, e, f, h [d] TSK somatic
focus
49.074 8 0.281 0.646 0.422
4 a, b, e, h [f] follow-up
pain intensity
48.193 7 0.277 0.881 0.348
5 a, b, e [h] follow-up
TSK act. avoid-
ance
46.378 6 0.268 1.815 0.178
6 a, e [b] follow-up
time
46.112 5 0.267 0.266 0.606
7 a [e] TSK activity
avoidance
44.069 4 0.256 2.043 0.153
2LL, K2LogLikelihood statistic; df, degrees of freedom; R2, Nagelkerke pseudo R2; LRtest, likelihood ratio test of variable removed; sign., P-value for
variable removed.
a Known risk factors: age, level of education, number of previous episodes, pain intensity.
b Follow-up time: number of days between baseline and end of study questionnaire.
c Measured at baseline.
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The final model explaining end of study Graded Chronic
Pain Scale scores included age, pain intensity, number of
previous episodes, level of education and negative affect.
Similar results were found for the prediction of 3, 6, and 12
months’ chronic pain grades; pain-related fear variables were
removed from the model each time. Secondary analyses in
which 3 and 6 months’ variables were, respectively, used as
predictors of end of study GCPS did not confirm pain-related
fear to be relevant at a later stage during follow-up either
(disability was only significant predictor).
3.6. Post hoc analyses
After interpreting and discussing these results, some post
hoc analyses have been performed on alternative models. As
the backgrounds of these analyses are best explained within
the context of the discussion, they are presented in Section 4.
4. Discussion
The aim of the present study was to test the longitudinal
validity of the fear–avoidance model using rigorous meth-
odological, psychological and statistical methods. The results
did not clearly support the fear–avoidance model in explaining
the transition from acute LBP to long-term outcome.
4.1. Methodological strengths and weaknesses
In the present study in–en exclusion criteria were set to
explicitly select acute patients consulting with LBP as a
primary problem. However, since LBP is known for high
comorbidity with other functional disorders and psychiatric
symptoms, some degree of ‘contamination’ may have
occurred. On the other hand, it can be argued that this
‘contamination’ is an inevitable part of the real life situation
health care providers have to deal with, and as such should
not be eliminated for research validity reasons.
Furthermore, a strict approach was taken with regard to
analysis. As recommended by Pincus et al. (2002), we chose
to measure multiple fear–avoidance variables, but also
considered correlations and conceptual overlay. Adjustment
for known risk factors was performed by entering these
variables into the model before fear–avoidance variables
were considered. The outcome variable used (Graded
Chronic Pain Scale) properly reflected the aspect of transition
in that it is categorical with proven relevant changes between
categories. A critical remark can be made about using an
adapted version instead of the original instrument for the
secondary measurements in this study. It is unlikely,
however, that this has significantly influenced the results.
Another critical comment can be made with respect to
sample size and statistical power. Based on incidence rates
and data on prevalence of LBP in primary care, the number
of participants in this study was expected to be higher.
Furthermore, highly fearful patients are underrepresented in
our analyses, because we excluded the intervention group or
our concurrent trial. This will have reduced statistical
power, but probably did not bias results. Still, this is one of
the larger studies to date, and a dropout rate of 21.6% is
relatively low compared to similar studies, for example by
Klenerman et al. (1995). Nevertheless, recruiting acute
patients and following them for more than a year seems to
highly interfere with daily GP practice (recruitment) and
patient interest and motivation (dropout).
An important topic not addressed by Pincus et al. (2002)
is the length of follow-up. A long follow-up period is
necessary in prospective cohort studies on LBP outcome. As
Von Korff et al. (1993) and Wahlgren et al. (1997) pointed
out, LBP runs a capricious course with many patients
recovering soon, a few becoming trapped in a chronic pain
syndrome, and most dealing with recurrent pain of variable
severity. In our opinion, a follow-up time of at least 1 year is
required to capture the recurrent nature of LBP. By adding a
cross-sectional end of study outcome measurement, the
number of patient years covered was almost doubled.
4.2. Post hoc considerations
A rather basic and conceptual point of discussion we
encountered during this study concerns the definition of
LBP outcome and the choice of endpoints. Traditionally,
and for theoretical reasons, researchers in chronic pain
usually define negative outcome in terms of prolonged
disability resulting from an isolated LBP episode. As with
this study attention is shifted towards acute/recurrent LBP in
primary care patients, we alternatively chose to interpret the
Graded Chronic Pain Scale score at end of study as a status
report of a patient’s LBP career as a whole (including pain
and disability, relapses and periods of recovery). In our
opinion, this approach more closely resembles reality in
general practice; GPs do not follow-up on many distinctly
chronic cases, most patients consult periodically with
intermittent complaints of both pain and dysfunction. This
Table 5
Prediction of end of study Graded Chronic Pain Scale: final model details
Predictor
variable
par. est. ORa 95% CI




0.773 2.166 1.629 2.881
Level of
education




0.017 1.017 1.004 1.030
par. est.Zparameter estimate; ORZodds ratio; 95% CIZ95% confidence
interval of odds ratio.
a Ordinal regression OR compares the odds of outcome being above vs.
below each of the possible cutpoints (grades I–IV vs. grade 0, grades II–IV
vs. grade 0 or I, etc.) when the independent variable increases with 1 unit.
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operationalisation of primary outcome may, however, be
criticised for being vulnerable to not finding existing
associations between pain-related fear and disability as
found in chronic patients, because the lower end of the
GCPS-spectrum is determined by pain intensity instead of
disability. Indeed, we did not find these relations—so do
they not exist in acute stages of LBP, or did we fail to detect
them? We reanalysed our data along the ‘chronic disability’
line of investigation. A logistic regression analysis was
performed with chronic disability (yes/no) as a dichotomous
outcome. Chronic disability was defined as a GCPS score of
III or IV at both 6 and 12 months follow-up. The results
were similar to those of our primary strategy; no
associations were found between baseline fear–avoidance
and outcome (disability). However, a drawback of this latter
strategy is low power, as not many cases qualified as
chronic. On the whole it seems that, whatever approach one
may prefer, the only conclusion possible from this set of
data is that the fear–avoidance model cannot be confirmed.
Along with the discussion about whether to investigate
isolated LBP episodes or entire patient careers, the circularity
of the fear–avoidance model further complicates analysis.
Although our sample was selected to contain new acute LBP
episodes, patients brought their previous LBP experience
with them. It must be assumed that the effects of the fear–
avoidance variables acting in the index episode is visible in
our analyses, while earlier influences (that is: in previous
episodes) may appear as an influence of fear–avoidance
variables, of previous episodes, or both. Therefore, in our
primary analysis (including the effect of previous episodes)
the true influence of fear–avoidance may be underestimated.
We compared this model post hoc to an alternative model not
containing the influence of previous episodes. This latter
model will result in an overestimation of the effect of fear–
avoidance; the truth may be somewhere in between both
estimates. However, the results show that fear–avoidance
was not a significant predictor in either model. From this it
can be concluded that, whether or not corrected for previous
LBP experiences, within the present sample fear–avoidance
variables do not add to the prediction of LBP outcome—not
within the light of the indexed episode, nor within the
perspective of the development of LBP career.
4.3. Theoretical and clinical implications
The results of this study together with that of Burton et al.
(1995) do not favour the fear–avoidance model. Opposite
evidence is provided by six studies in support of the theory
(Buer and Linton, 2002; Fritz et al., 2001; Klenerman et al.,
1995; Linton et al., 2000; Picavet et al., 2002; Sieben et al.,
2002). However, comparing results and explaining differ-
ences found between studies is difficult, as study popu-
lations, measures used, follow-up periods and analyses vary
highly, thus limiting possibilities to generalize. The current
study may add to evidence in that it does not invalidate fear–
avoidance theory, but at least raises doubt about its role
early in a LBP episode. It is beyond dispute that the fear–
avoidance model is well established as a perpetuating factor
once chronicity has developed, but we could not confirm its
significance in non-chronic cases.
In an attempt to explain this discrepancy it can be argued
that at baseline we captured very early processes, since
negative affect turned out to be the only predictive fear–
avoidance variable at baseline. Negative affect is regarded
to be a vulnerability factor and potential precursor of pain-
related fear. However, pain-related fear did not become a
relevant factor at later stages during follow-up.
Of course it is also possible thatno long-term effect of pain-
related fear exists at all in this sample. In contrast with many
chronic patients, the majority of general practice LBP patients
will have learned how to cope with their LBP. Although a
recurrent problem, they may have found a way to deal with it
and take flare-ups for granted to some extent. Only when an
episode isexperiencedas ‘different’ fromprevious ones,pain-
related fear may raise to pathological levels. In other
circumstances, some degree of fear and avoidance may even
benefit acute stage recovery, as it reduces nociception and
facilitates tissuehealingduring thefirst fewdays(Wall,1979).
The more ‘dangerous’ aspect of prolonged avoidance in that it
deprives thepatient fromcorrecting learning experiences may
be less important because these patients are mostly active,
working people who nevertheless will (be forced to) resume
their normal activities as soon as possible. In this way their
pain-related fear will naturally be confronted and reduced
before it becomes problematic.
Another option is that the fear–avoidance model alone
may be insufficient to explain the transition to chronic LBP.
Pain-related fear will only show to be predictive of outcome,
if it is the most prevalent pathway to chronicity. A general
influence of, for instance, negative affect/depressive mood as
a vulnerability factor for chronic pain may be more prevalent
and obscure the effect of fear–avoidance at the group level.
Future prospective studies might benefit from broadening the
scope and including possible co-existing models.
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